Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed. This reflects an update to the record's version history rather than changes to the study content or data.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, reflecting an update to the record. The previous revision v3.6.3 is removed from the visible history.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.3) and removes the previous revision (v3.6.1), indicating an update to the page's version history.SummaryDifference0.1%

- Check52 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.1), updating the version history. This replaces the previous v3.6.0 entry.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous v3.5.4 entry was removed. This reflects an update to the page's revision record.SummaryDifference0.1%

- Check89 days agoChange DetectedThe Record History now includes a new revision entry, v3.5.4, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata rather than any change to the study content.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.